U.S. Precision Biosciences prices $132 mln initial public offering

03/20/2019 6:08:00 AM (GMT)

U.S. genome editing company Precision Biosciences has priced its $132 million initial public offering (IPO).

The company priced the IPO between $15 to $17 per share.

Precision BioSciences has raised a total of $175.2 million in over four funding over 4 rounds.

Annually, the company books around $6 million in revenue.

Precision BioSciences Inc.

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text